mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Breast cancer research and treatment

Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. 2014.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. Breast cancer research and treatment. 2014.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Breast cancer research and treatment

Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. 2014.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. Breast cancer research and treatment. 2014.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Breast cancer research and treatment

Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. 2014.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Wilson-Edell KA, Yevtushenko MA, Rothschild DE, Rogers AN, Benz CC. Breast cancer research and treatment. 2014.